Bukit Uluwatu Villa Tbk vs Cipta Sarana Medika Tbk. — how do they compare? Bukit Uluwatu Villa Tbk trades at Rp725 (market cap 18.59T, 72.39M 24h volume), while Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 14.05M 24h volume). The key difference: Bukit Uluwatu Villa Tbk is far larger — about 115.7× Cipta Sarana Medika Tbk.'s market cap, and Bukit Uluwatu Villa Tbk is more actively traded (72.39M versus 14.05M). Which is the better fit depends on your goals.
| BUVA | DKHH | |
|---|---|---|
Market Cap | 18.59T | 160.67B |
Volume | 72.39M | 14.05M |
Lot | 723.87K | 140.49K |
Turnover | 53.33B | 899.67M |
Average Price | 736.69 | 64.04 |
Value | 53.33B | 899.67M |
Indicative Equilibrium Price | 725 | 64 |
Indicative Equilibrium Volume | 12.22K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bukit Uluwatu Villa Tbk (the “Company”) was established in the Republic of Indonesia on December 15, 2000 based on the Notarial Deed No. 53 of Sugito Tedjamulja, S.H.. The Company’s status has been changed from foreign investment company (PMA) to domestic investment company (PMDN).
Read more on BUVA →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →